Screening results of African migrants entering the coasts of Italy in 2017 are presented and compared to results of migrants entering the Original Article
Original Articles
Clinical Social Work and Health Intervention Vol. 8 No. 3 2017 
Results and discussion
There was significant difference among two groups of migrants. Screening tests for malaria, HIV, HCV and HBV were significantly more often positive in the group of African migrants than in the migrants from the Middle East (0.5% vs. 8.5% HIV, 2.5% vs. 9% HBV, 0% vs. 5% HCV, 0% vs. 35% for malaria, p>0.05).
Conclusions
Refugees from the African continent are more likely to be hosts of HBV, HCV, HIV and malaria. Screening strategies should be therefore considered for various populations.
Background
Two major waves of refugees entered Europe in 2015; first via Greece and Turkey. The second wave entered Europe via Sicily and Malta using maritime transport. There were many papers published on differences between these two groups as far as communicable diseases are concerned. Diseases, such as malaria and other parasitic diseases were more prevalent in the group entering Malta and Sicily, probably due to the different origin of the migrants. The aim of this short paper was to compare results of the rapid tests for HIV, HBV, HCV and malaria in the groups of migrants of different origin using different points of entry to Europe.
Methods
Comparison of the results of screening tests for HBV, HIV and HCV was performed in two groups of migrants. The first group consisted of 199 migrants from Syria, Iraq and Afghanistan who stayed in the asylum and refugee camp in Veria, Greece. The second group consisted of prevalently African migrants (in total of 203), who were screened at refugee camp. Their main countries of origin were Somalia, Eritrea and Ethiopia.
EU via Greece. Occurrence of all screened diseases (HCV, HBV, HIV and malaria) was significantly higher among African migrants in comparison to those who were staying in camps or migrated via the Balkan route. 
